Laval, Quebec-based Valeant Pharmaceuticals International, Inc. (VRX) announced today that it will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for about $800 million and contingent payments. Amoun Pharmaceutical is one of the leading drug makers in Egypt. It has a large manufacturing facility in El-Oubour City, a suburb near Cairo, and five […]